HE

Hannelore Ehrenreich

SK Sygnis Bioscience Gmbh & Co. Kg: 1 patents #14 of 28Top 50%
Overall (All Time): #847,483 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
9254312 Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis Klaus-Armin Nave 2016-02-09
9180165 Use of EPO receptor activation or stimulation for the improvement of the EDSS score in patients with multiple sclerosis 2015-11-10
8691767 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses 2014-04-08
8168589 Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses 2012-05-01
7514072 Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia Christoph Gleiter 2009-04-07
7361681 Method of treating amytrophic lateral sclerosis using melatonin Ruediger Hardeland, Klaus-Armin Nave, Jochen Weishaupt 2008-04-22